Abstract
Rapidly progressive renal failure is a common but severe feature of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A histopathological classification for ANCA-associated pauci-immune glomerulonephritis was developed for prognostication of these patients. The present study aims to classify patients of pauci-immune glomerulonephritis according to this classification and its impact on outcome. Eighty-six subjects with pauci-immune glomerulonephritis between July 2006 and October 2012 were included in the study. Their renal biopsies were reviewed and classified into focal, crescentic, sclerotic and mixed class as per the new classification. The outcomes were analyzed after 6 months of treatment. Of the 86 subjects, 34 (39.53 %) were granulomatosis with polyangiitis, 36 (41.86 %) microscopic polyangiitis, 1 eosinophilic granulomatosis with polyangiitis, while the rest (17.44 %) were unclassifiable. Thirteen (15.5 %), 43 (51.2 %), 12 (14.3 %) and 16 (19 %) patients were classified as focal, crescentic, sclerotic and mixed class, respectively. The mean serum creatinine at baseline was 280.23, 659.46, 573.72 and 542.78 µmol/L in focal, crescentic, sclerotic and mixed class, respectively. The probability of improvement in renal functions at 6 months decreased from focal to crescentic to mixed to sclerotic class, while the probability of death was highest in the sclerotic class followed by the mixed class. This difference in outcome was maintained irrespective of the clinical diagnosis or the Birmingham Vasculitis Activity Score. Our study has shown that the histopathological classification can be used to predict the severity of renal dysfunction as well as the treatment outcomes in pauci-immune glomerulonephritis.
Similar content being viewed by others
References
de Lind Van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264–2274
Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628–1636
Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ, the Glomerular Disease Collaborative Network (1996) Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23–32
Day CJ, Howie AJ, Nightingale P, Shabir S, Adu D, Savage CO, Hewins P (2010) Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis 55:250–258
Rais-Jalali G, Khajehdehi P (1999) ANCA-associated glomerulonephritis: relationship of main ANCA subtypes to renal outcome, age and sex of the patients. Ann Saudi Med 19:413–416
Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A (2003) Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients. Nephrol Dial Transplant 8(Suppl 5):S5–S7
Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143:621–631
Alexopoulos E, Gionanlis L, Papayianni E, Kokolina E, Leontsini M, Memmos D (2006) Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN). BMC Nephrol 7:16
Ahn JK, Hwang JW, Lee J, Jeon CH, Cha HS, Koh EM (2012) Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int 32:2979–2986
Flossmann O, Berden A, de Groot K et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488–494
Sinico RA, Toma LD, Radice A (2013) Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 12:477–482
Gigante A, Salviani C, Giannakakis K et al (2012) Clinical and histological outcome predictors in renal limited pauci-immune crescentic glomerulonephritis: a single centre experience. Int J Immunopathol Pharmacol 25:287–292
Rupcic V, Jakic M, Rupcic V, Viziak V, Fijacko M (2011) Clinical course and outcome predictors in pauci-immune ANCA positive renal limited vasculitis. Acta Clin Croat 50:475–483
Itabashi M, Takei T, Yabuki Y (2010) Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody associated vasculitis in Japan. Nephron Clin Pract 115:c21–27
vasculitis.org [internet] Birmingham Vasculitis Activity Score (version 3). http://www.vasculitis.org/images/documents/bvas_v3.0.pdf
Rajappa M (2002) Assessment of activity and damage in ANCA-associated vasculitis in India. Arthritis Res 4(Suppl 1):88
Lane SE, Watts RA, Shepstone L, Scott DGI (2005) Primary systemic vasculitis: clinical features and mortality. Q J Med 98:97–111
Itabashi M, Yumura W, Tsukada M, Shirota S, Takei T, Ogawa T, Yoshida T, Uchida K, Tsuchiya K, Nitta K (2008) Clinico-histopathological analysis of renal changes in MPO ANCA associated vasculitis. Nihon Jinzo Gakkai Shi 50:927–933
Chang D, Wu L, Liu G, Chen M, Kallenberg CGM, Zhao MH (2012) Re-evaluation of the histopathological classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single centre. Nephrol Dial Transplant 27:2343–2349
Martinez-Morillo M, Grados D, Naranjo-Hans D, Mateo L, Holgado S, Olive A (2012) Granulomatosis with polyangiitis (Wegner). Description of 15 cases. Reumatol Clin 8:15–19
Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498
Seck SM, Dussol B, Brunet P, Burtey S (2012) Clinical features and outcomes of ANCA associated renal vasculitis. Saudi J Kidney Dis Transplant 23:301–305
Mahr A, Katsahian S, Varet H, for the French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS) et al (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody associated vasculitis: a cluster analysis. Ann Rheum Dis 72:1003–1010
Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B, French Vasculitis Study Group (2001) Long term follow up of polyarteritis nodosa, microscopic polyangiitis and Churg–Strauss syndrome. Arthritis Rheum 44:666–675
Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D (2003) Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 41:539–549
Suppiah R, Mukhtyar C, Flossmann O (2011) A cross sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 50:899–905
Frausova D, Brejnikova M, Hruskova Z, Rihova Z, Tesar V (2008) Outcome of thirty patients with ANCA associated renal vasculitis admitted to the intensive care unit. Ren Fail 30:890–895
Iwakiri T, Fujimoto S, Kitagawa K (2013) Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol 14:125
Dadoniene J, Pileckyte M, Baranauskaite A, Kirdaite G (2010) Clinical characteristics and long-term outcomes of 35 patients with Wegener’s granulomatosis followed up at two rheumatology centers in Lithuania. Medicina (Kaunas) 46:256–260
Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M, Aral O, Inanc M (2010) Predictors of damage and survival in patients with Wegener’s granulomatosis: analysis of 50 patients. J Rheumatol 37:374–378
Stevic R, Jovanovic D, Obradovic LN, Milenkovic B, Skodric-Trifunovic V, Stankovic I (2012) Wegener’s granulomatosis: clinic-radiological finding at initial presentation. Coll Antropol 36:505–511
De Souza FH, Radu Halpern AS, Valente Barbas CS, Shinio SK (2010) Wegener’s granulomatosis: experience from a Brazilian tertiary centre. Clin Rheumatol 29:855–860
Tural C, Cuxart A, Bertran X, Puigdengoles X, Segura A, Rey-Joly C (1992) Granulomatosis de Wegener: descripcion de 6 pacientes. Med Clin 99:63–66
Ríos Blanco JJ, Gómez Cerezo J, Vázquez Muñoz E, Suárez García I, López Rodríguez M, Yébenes Gregorio L, Torres Sánchez I, Barbado Hernández FJ (2005) Clinical-biological and radiological study of Wegener’s granulomatosis in a university hospital. Rev Clin Esp 205:367–373
Kapitsinou PP, Ioannidis JPA, Boletis JN, Sotsiou F, Nakopoulou L, Daphnis E, Moutsopoulos HM (2003) Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis 41:29–37
Hauer HA, van Houwelingen HC, Bajema IM, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS) (2002) Renal histology in ANCA associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61:80–89
Vergunst CE, van Gurp E, Hagen EC et al (2003) An index for renal outcome in ANCA associated glomerulonephritis. J Kidney Dis 41:532–538
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naidu, G.S.R.S.N.K., Sharma, A., Nada, R. et al. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome. Rheumatol Int 34, 1721–1727 (2014). https://doi.org/10.1007/s00296-014-3041-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-014-3041-z